OpenAlex
PricingAboutJobs
Log inGet started
Work

Pharmacophore-based models for therapeutic drugs against phosphorylated tau in Alzheimer’s disease

HTML

Year: 2018
Type: review
Source: Drug Discovery Today
DOI: 10.1016/j.drudis.2018.11.005
Authors: Jangampalli Adi Pradeepkiran, Arubala P. Reddy, P. Hemachandra Reddy
Institutions: Texas Tech University Health Sciences Center, Texas Tech University
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: phosphorylated tau, Alzheimer's disease, pharmacophore model, amyloid-beta, Drp1, mitochondrial fission, mitochondrial fragmentation, synaptic damage, tauopathy
SDG: Good health and well-being

Open Access status: green

Funders: CH Foundation, Garrison Family Foundation, National Institute on Aging, National Institute of Neurological Disorders and Stroke
Awards: Small Molecule Inhibitor Therapeutic Target for Alzheimer's Disease., Mitochondrial Fragmentation and Neurodegeneration in Huntington's Disease, Dynamin-Related Protein 1 and Mitochondrial Fragmentation in Alzheimer's Disease, Voltage-Dependent Anion Channel and Neurodegeneration in Alzheimer's Disease
OpenAlex ID: W2900998599
FWCI: 0.78
Cites: 88
Cited by: 55
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security